NCT06335394View on ClinicalTrials.gov

Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 2, 2018

Primary Completion Date

April 27, 2022

Study Completion Date

May 15, 2028

Conditions
Recalcitrant Lower Limb Nonunion
Interventions
OTHER

NVD003

Autologous osteogenic implant NVD-003 for bone reconstruction

Trial Locations (10)

1020

Centre Hospitalier Universitaire CHU/UVC Brugmann (Site Horta), Brussels

1070

Centre Hospitalier Interregional Edith Cavel (CHIREC) - Clinique Ste Anne-St Remi, Anderlecht

1210

Centre Hospitalier de Luxembourg, Luxembourg

3000

Universitair Ziekenhuis Leuven, Campus Gasthuisberg, Leuven

3600

Ziekenhuis Oost-Limburg (ZOL), Genk

5000

Centre Hospitalier Regional De Namur, Namur

7000

CHU Ambroise Paré, Mons

8000

Algemeen Ziekenhuis (AZ) Sint-Jan Brugge - Oostende AV - Campus Sint-Jan, Bruges

Unknown

Grand Hôpital De Charleroi, Charleroi

University Hospital Basel, Basel

Sponsors
All Listed Sponsors
lead

Novadip Biosciences

INDUSTRY

NCT06335394 - Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion | Biotech Hunter | Biotech Hunter